LIST OF BINDING INTERFACES for query 'FIBROBLAST GROWTH FACTOR RECEPTOR 1' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
4v04	0LI	Ponatinib (DB08901)	Ponatinib is a kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML).	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B (Homo sapiens)	PK_Tyr_Ser-Thr	4V04_A_0LIA1772	Details
5ew8	5SF	Erdafitinib (DB12147)	Erdafitinib is a fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	5EW8_A_5SFA803	Details
5zv2	LEV	Lenvatinib (DB09078)	Lenvatinib is a receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma.	FIBROBLAST GROWTH FACTOR RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	5ZV2_A_LEVA801	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["4v04","0LI","Ponatinib (DB08901)","Homo sapiens","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","PK_Tyr_Ser-Thr"],["5ew8","5SF","Erdafitinib (DB12147)","Homo sapiens","FIBROBLAST GROWTH FACTOR RECEPTOR 1","PK_Tyr_Ser-Thr"],["5zv2","LEV","Lenvatinib (DB09078)","Homo sapiens","FIBROBLAST GROWTH FACTOR RECEPTOR 1","PK_Tyr_Ser-Thr"]]